What Blue Heron Capital does

Blue Heron Capital is a private early-stage growth equity firm headquartered in Richmond, Virginia, founded in 2006 with first disclosed portfolio activity in 2013. The firm invests growth equity and minority positions in healthcare technology and services businesses and select enterprise technology platforms, targeting companies at the $3–$20 million revenue stage with high growth, strong gross margins, capital efficiency, and experienced management teams open to active investor engagement.

The firm's central differentiated product is the OA Collaborative — a network of 45+ Operating Advisors (seasoned entrepreneurs and operating executives) that supplements Blue Heron's 8-person core investment team. This network actively sources deals, contributes diligence, and engages with portfolio companies across strategy, talent, and execution. The OA Collaborative is positioned as "human capital" paired with financial capital and is the firm's primary mechanism for portfolio value creation. Co-founders Tom Benedetti and Andrew Tichenor, each with 30+ years of relevant experience, anchor the firm alongside Operating Partner Jim Riley, who brings a documented track record (5.8x average MOIC across 7 VC/PE-backed companies, $2B cumulative enterprise value at exit).

Blue Heron generates revenue through standard VC economics: management fees on committed and invested capital across at least three successive funds (Fund I, II, III), and carried interest from exits including Verisma (6.9x MOIC, 40% IRR), Stratasan (3.3x MOIC, 53% IRR), STARC Systems (38% CAGR during hold), Avizia (acquired by Amwell), and Amwell (IPO). The firm manages 20+ active and 12+ exited portfolio companies, with deal flow sourced through OA Collaborative referrals, direct CEO relationships, and co-investor networks (Catalyst Investors, Long Ridge, Nuveen, Peterson Partners, Toba Capital, SpringTide, Communitas Capital). Underlying technology is minimal — investor portal and cap table administration run on Carta, with no proprietary investment platform disclosed.

Name

Blue Heron Capital

Legal name

Blue Heron Capital

Website

http://www.blueheroncap.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Blue Heron Capital is a Richmond, VA-based private growth equity firm investing minority positions in healthcare and enterprise technology companies at $3–$20 million revenue, pairing financial capital with its 45-member OA Collaborative of operating advisors to actively support portfolio CEOs through exit.

Ownership category

akta.pro rank

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Management Fees & Carried Interest: As a growth equity / venture capital firm operating multiple funds (Fund I, Fund II, Fund III referenced), Blue Heron Capital generates revenue through typical VC economics: management fees on committed/invested capital across portfolio funds and carried interest on successful exits. Historical exits include Verisma (6.9X MOIC, 40% IRR), Stratasan (3.3X MOIC, 53% IRR), STARC Systems, Avizia (sold to American Well), Verima, Amwell (exited via IPO), and others.
2. Capital Gains from Portfolio Exits: Returns generated from successful exits of portfolio company investments across healthcare and enterprise technology — including acquisitions by strategic buyers (American Well for Avizia, AdaptHealth for DuraMedic, Spectrum Equity/Rise Fund for PresenceLearning, Brown & Brown for Tricast, NewSpring Capital for Verisma, Syntellis for Stratasan, North Branch Capital for STARC Systems) and IPOs (Amwell).

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

Blue Heron Capital is an early-stage growth equity firm that makes minority investments in healthcare technology and services businesses and select enterprise technology platforms with $3-$20 million in revenue. Each investment is paired with access to the firm's OA Collaborative, a 45+ member network of operating advisors and seasoned entrepreneurs who provide portfolio companies with hands-on mentorship, board representation, sourcing, and strategic guidance. The firm manages multiple successive funds (Fund I, Fund II, Fund III) that deploy capital via typical VC economics of management fees and carried interest.

Product overview

Blue Heron Capital operates a single integrated service platform centered on early-stage growth equity investing combined with its proprietary OA Collaborative support program. The Growth Equity Investment Program constitutes the core offering, investing in healthcare (technology-based and services businesses addressing cost containment, patient experience, better care, technology innovation, and aging in place) and enterprise technology (B2B platforms with high switching costs, attractive growth, scalable technology, and potential healthcare applications). The OA Collaborative is the differentiated value-add layer that wraps every investment: an in-house network of operating advisors and seasoned entrepreneurs providing hands-on mentorship, market insight, sourcing, board representation, and strategic guidance to portfolio CEOs across the investment life cycle. Blue Heron Fund III is the current fund vehicle that deploys capital sourced through this platform. Together, these two elements (capital + human capital OA Collaborative) form a unified platform-plus-services architecture rather than a modular software product.

Differentiator

Problem solved

Functional benefit

Brands

• OA Collaborative: An extensive network of seasoned professionals and successful entrepreneurs (Operating Advisors) who engage with portfolio companies in leadership, insight, and networking to accelerate their growth.

Products and services

• Growth Equity Investment Program Early-stage growth equity investment program targeting healthcare and select enterprise technology companies with $3-$20 million in revenue, structured as minority positions with active investor engagement.
• OA Collaborative (Operating Advisor Collaborative) Proprietary network of 45+ seasoned entrepreneurs and operating executives who actively engage portfolio companies on strategy, sourcing, board-level guidance, market intelligence, and acquisition target identification.
• Blue Heron Fund III Blue Heron Capital's third successive investment fund vehicle, with an investment committee that includes Operating Partner Jim Riley, used to deploy capital into healthcare and enterprise technology portfolio companies.
• OA Collaborative Membership Program Application-based membership program inviting experienced operators to join the OA Collaborative network, providing access to proprietary investment opportunities and the ability to engage with portfolio companies as advisors and mentors.

Quantifiable outcome

• 5.8x average MOIC across 7 VC/PE-backed companies Jim Riley was involved with
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core operations dependency, flagship — full portfolio and historical — completed exits.

• Carta (Investor Portal Technology)core operations dependencyTechnology or IntegrationBlue Heron Capital uses Carta's platform (app.carta.com) for investor login and capital account management — a standard VC fund administration / cap table infrastructure relationship.
• Blue Heron Capital Active Portfolio Companiesflagship — full portfolioStrategic or Co-development PartnerBlue Heron's active investments where the firm provides growth equity capital plus OA Collaborative human capital: Acclivity Health (Jacksonville, FL), AnswersNow (Richmond, VA), Authenticx (Indianapolis, IN), BlackCloak (Orlando, FL), Buildforce (Houston, TX), ChartSpan (Greenville, SC), Cookie Finance, Homecare.com/ShiftMed (McLean, VA), Kion (Fulton, MD), Mimecast (London, England), Motionworks (Atlanta, GA), Proof (Denver, CO), Redi Health (Columbus, OH), Remission Medical (2026), ShowdMe (New York, NY), Tava Health (Salt Lake City, UT), Vend Park (Boston, MA), Verato, VIDA (Coralville, IA), Yes Hearing (New York, NY).
• Blue Heron Capital Exited Portfolio Companieshistorical — completed exitsStrategic or Co-development PartnerExited investments include Amwell (exited via IPO), Apogee IT Services (Sewickley, PA), Avizia (acquired by American Well), Aware, DuraMedic (acquired by AdaptHealth), PresenceLearning (acquired by Spectrum Equity & The Rise Fund), RevealRX (acquired by HealthPlan Data Solutions), STARC Systems (Brunswick, Maine — acquired by North Branch Capital), Stratasan (acquired by Syntellis), Tricast (acquired by Brown & Brown), Verisma (acquired by NewSpring Capital).

Scale indicators13 records

Recent moves9 records

Expansion highlights5 records

Emerging players

• SpringTide Ventures: Healthcare-focused early-stage venture firm investing across care delivery, digital health, and health IT. Co-investor with Blue Heron in Tava Health Series B and directly comparable at Series A/B healthcare stage.
• Echo Health Ventures: Healthcare-focused growth equity platform formed by Cambia Health Solutions and Mosaic Health Solutions. Direct healthcare overlap with Blue Heron's portfolio with smaller fund size and emerging deal flow.
• Health Catalyst Capital: Healthcare-dedicated growth equity firm investing in healthcare IT, services, and technology-enabled care delivery. Comparable in vertical focus and growth-stage orientation though narrower sector mandate than Blue Heron's enterprise tech exposure.

Direct peers

• .406 Ventures: Boston-based early-stage growth equity firm investing in healthcare IT, healthcare services, and enterprise technology companies at similar revenue stages. Most directly comparable to Blue Heron in fund size, vertical focus, and active-investor model.
• Edison Partners: Princeton-based growth equity firm investing in high-growth technology-enabled services and healthcare companies. Comparable in check size, stage, and active-investor approach with sector specialization similar to Blue Heron's thesis.
• Catalyst Investors: New York-based growth equity firm focused on lower middle-market software, healthcare IT, and business services. Direct co-investor with Blue Heron in Tava Health and comparable in stage and sector focus.
• Long Ridge Equity Partners: Growth equity firm focused on high-growth, capital-efficient businesses in financial and business services. Direct co-investor with Blue Heron in Proof ($30.4M Series B led by Long Ridge) at overlapping stage and active-investor model.

Broad incumbents

• Optum Ventures: The dedicated healthcare growth equity arm of UnitedHealth Group/Optum, investing broadly across digital health, care delivery, and health tech. Larger and better-capitalized competitor targeting the same healthcare thesis that dominates Blue Heron's portfolio.
• General Atlantic: Large global growth equity investor with deep healthcare and technology franchises. Competes for the same enterprise tech and healthcare growth-stage opportunities as Blue Heron but at materially larger check sizes and follow-on capacity.
• Norwest Venture Partners: Established venture and growth equity firm with healthcare and technology as two of its largest investment pillars. Competes for similar Series A/B opportunities in Blue Heron's verticals with a longer track record and broader LP base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/blue-heron-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments43 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blue Heron Capital